You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

HYDROXYZINE PAMOATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Hydroxyzine Pamoate, and what generic alternatives are available?

Hydroxyzine Pamoate is a drug marketed by Barr, Beximco Pharms Usa, Duramed Pharms Barr, Heritage Pharma, Impax Labs Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Superpharm, Vangard, and Watson Labs. and is included in thirty-four NDAs.

The generic ingredient in HYDROXYZINE PAMOATE is hydroxyzine pamoate. There are nineteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the hydroxyzine pamoate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Hydroxyzine Pamoate

A generic version of HYDROXYZINE PAMOATE was approved as hydroxyzine pamoate by SANDOZ on December 31st, 1969.

  Try a Trial

Drug patent expirations by year for HYDROXYZINE PAMOATE
Drug Prices for HYDROXYZINE PAMOATE

See drug prices for HYDROXYZINE PAMOATE

Drug Sales Revenue Trends for HYDROXYZINE PAMOATE

See drug sales revenues for HYDROXYZINE PAMOATE

Recent Clinical Trials for HYDROXYZINE PAMOATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shalvata Mental Health CenterN/A

See all HYDROXYZINE PAMOATE clinical trials

Pharmacology for HYDROXYZINE PAMOATE
Drug ClassAntihistamine
Mechanism of ActionHistamine Receptor Antagonists
Anatomical Therapeutic Chemical (ATC) Classes for HYDROXYZINE PAMOATE

US Patents and Regulatory Information for HYDROXYZINE PAMOATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 086705-001 Jul 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 081165-001 Jul 31, 1991 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 087767-001 Aug 16, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 086698-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Barr HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 088496-001 Jun 15, 1984 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.